Please provide your email address to receive an email when new articles are posted on . The addition of amivantamab-vmjw to chemotherapy extended PFS among a subset of patients with non-small cell ...
Intratumoral delivery of an engineered oncolytic virus (DNX-2401) targeting glioblastoma (GBM) cells combined with subsequent immunotherapy was safe and improved survival outcomes in a subset of ...
Patients with metastatic castration-resistant prostate cancer who do not benefit from chemotherapy need more effective treatment options Phase 2 CheckMate 650 trial found ipilimumab plus nivolumab ...
Please provide your email address to receive an email when new articles are posted on . A three-drug combination demonstrated activity for patients with microsatellite-stable, BRAF V600E-positive ...
Rivoceranib plus Airuika demonstrates improvement for survival in patients with unresectable hepatocellular carcinoma, a subset of liver cancer. The treatment combination of rivoceranib (apatinib) and ...
The treatment combination of Rybrevant plus chemotherapy offers better progression-free survival for patients with advanced EGFR exon 20 insertion-positive NSCLC. The treatment combination of ...
Hosted on MSN
New approach for testing multiple treatment combinations at once could aid in development of cancer drugs
MIT researchers have developed a new theoretical framework for studying the mechanisms of treatment interactions. Their approach allows scientists to efficiently estimate how combinations of ...
Efficacy and safety of bronchial arterial chemoembolization (BACE) in combination with tislelizumab for non-small cell lung cancer (NSCLC): A phase II study.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results